Results 21 to 30 of about 228,568 (289)

Update on Viral Gene Therapy Clinical Trials for Retinal Diseases

open access: yes, 2022
In 2001, the first large animal was successfully treated with a gene therapy that restored its vision. Lancelot, the Briard dog that was treated, suffered from a human childhood blindness called Leber's congenital amaurosis type 2.
Cheng, Shun-Yun, Punzo, Claudio
core   +1 more source

Vergence and Accommodation Cues in Stereo-Localization during the Small-In Large-Out (SILO) Effect

open access: yesVision, 2022
A typical procedure in vision therapy is the use of Quoits vectograms to train fusional vergence ranges by improving stereo-localization, which is the ability to correctly locate the target stimulus in space.
Marc Argilés   +3 more
doaj   +1 more source

Current perspective: Cerebral visual impairment—The impending doom

open access: yesIndian Journal of Ophthalmology, 2023
Cerebral visual impairment (CVI) has emerged as an important cause of morbidity in young children. CVI children often have a large number of visual symptoms along with motor abnormalities.
Swati Phuljhele   +3 more
doaj   +1 more source

Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179 [PDF]

open access: yes, 2015
The rd1 mouse with a mutation in the Pde6b gene was the first strain of mice identified with a retinal degeneration. However, AAV-mediated gene supplementation of rd1 mice only results in structural preservation of photoreceptors, and restoration of the ...
Bainbridge, James W.B.   +35 more
core   +1 more source

Characterization, passive and active treatment in strabismic amblyopia: a narrative review [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
Strabismic amblyopia is characterized by a distorted spatial perception. In this condition, the neurofunctional disorder occurring during first years of life provoke several monocular and binocular anomalies such as crowding, deficits in the ...
Myriam Milla, David P. Piñero
doaj   +1 more source

Serious Games for Vision Training Exercises with Eye-Tracking Technologies: Lessons from Developing a Prototype

open access: yesInformation, 2022
Eye-tracking technologies (ETs) and serious games (SGs) have emerged as new methods promising better support for vision screening and training. Previous research has shown the practicality of eye-tracking technology for vision screening in health care ...
Qasim Ali   +3 more
doaj   +1 more source

Nystagmus vision therapy

open access: yesOphthaTherapy. Therapies in Ophthalmology, 2019
Specjalista ochrony wzroku, spotykając w swoim gabinecie pacjenta z oczopląsem, może mu pomóc rozwiązać problemy wzrokowe, wykorzystując zarówno rozwiązania optyczne, nieoptyczne, farmakologię i zabiegi chirurgiczne (okulista), jak i ćwiczenia wzrokowe ...
Gwara, Monika
openaire   +3 more sources

Doctoral Capstone Experience: Acute Care Occupational Therapy Neurological Vision Rehabilitation

open access: yes, 2021
Indiana University Purdue University IndianapolisThis paper focuses on an occupational therapy student’s Doctoral Capstone Experience (DCE) at a large, level I trauma hospital in the neurological rehabilitation department. The site lacked an occupational
Northquist, Jessie
core   +1 more source

Occupational Therapy Curricula Patterns for Acquired Brain Injury-Related Vision Disorders for Entry-Level Programs: A Survey

open access: yes, 2023
Occupational therapists are among the first providers to encounter individuals after an acquired brain injury (ABI). Evidence suggests that most occupational therapists learn about ABI-related vision disorders from continuing education and on-the-job ...
Foy, Caitlyn   +5 more
core   +1 more source

Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients [PDF]

open access: yes, 2012
Background: Objective techniques to assess the amelioration of vision in patients with impaired visual function are needed to standardize efficacy assessment in gene therapy trials for ocular diseases.
Melillo Paolo   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy